Bio-Rad Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Bio-Rad Laboratories has a total shareholder equity of $9.1B and total debt of $1.2B, which brings its debt-to-equity ratio to 13.3%. Its total assets and total liabilities are $12.6B and $3.6B respectively. Bio-Rad Laboratories's EBIT is $341.0M making its interest coverage ratio -6.6. It has cash and short-term investments of $1.7B.
Key information
13.3%
Debt to equity ratio
US$1.20b
Debt
Interest coverage ratio | -6.6x |
Cash | US$1.65b |
Equity | US$9.05b |
Total liabilities | US$3.56b |
Total assets | US$12.61b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BUW's short term assets ($3.1B) exceed its short term liabilities ($466.2M).
Long Term Liabilities: BUW's short term assets ($3.1B) do not cover its long term liabilities ($3.1B).
Debt to Equity History and Analysis
Debt Level: BUW has more cash than its total debt.
Reducing Debt: BUW's debt to equity ratio has increased from 8.8% to 13.3% over the past 5 years.
Debt Coverage: BUW's debt is well covered by operating cash flow (28.9%).
Interest Coverage: BUW earns more interest than it pays, so coverage of interest payments is not a concern.